Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The application discloses the following biomarkers for GDM (gestational diabetes mellitus): a. higher plasma level of insulin receptor (lR) expression on syncytiotrophoblast extracellular vesicles (STBEV) was observed in the GDM pregnancies compared to normal pregnancy (example of application p. 1 3 ll. 1 4-17). b. higher plasma levels of STBEV expressing Dipeptidyr peptidase rV (DPPIV) were observed in GDM pregnancies compared to normal pregnancies.

Type

Patent

Publication Date

12/03/2020

Addresses

Manu Vatish, University of Oxford, Oxford, United Kingdom

Keywords

Diagnostic, Gestational Diabetes, Extracellular Vesicles